Life-changing eye implant helps blind patients read again

Life-changing eye implant helps blind patients read again

Blind patients have received a life-changing implant that allows them to read again, bringing hope to those with an advanced form of dry age-related macular degeneration. A surgeon at Moorfields Eye Hospital in London described the results of the international trial as “astounding” after inserting microchips in five patients. Sheila Irvine, a 70-year-old registered blind individual, expressed her joy at being able to read and do crosswords again, calling it “beautiful” and “wonderful.”

Geographic atrophy, a condition that affects a small area of the retina, results in blurred or distorted central vision. The new procedure involves inserting a tiny photovoltaic microchip under the retina and using glasses with a built-in video camera to send images to the implant. Patients spent months learning how to interpret the enhanced images, with many experiencing meaningful vision that allowed them to read and write in their daily lives.

The technology, developed by California biotech Science Corporation, was tested on 38 patients in five European countries, with the majority experiencing significant improvements. Sheila, who had the implant fitted three years ago, expressed her delight at being able to read post, books, and solve puzzles. While the Prima implant is not yet licensed for commercial use, there are hopes that it may become available to NHS patients in the near future, offering a ray of hope for those with limited treatment options for AMD.

Sheila’s story showcases the transformative power of technology in restoring vision for those with degenerative eye conditions. While she does not wear the device outdoors due to the required concentration, she rushes her chores each day to sit down and put on the special glasses. The potential of the Prima implant to aid individuals with other eye conditions in the future is a promising development, offering hope to many who face vision challenges with currently limited treatment options

Read the full article from The BBC here: Read More